, Luettgen, J. ., Wang, Z. ., Frost, C. ., Yones, C. ., Russo, C. ., … Frost, R. . (2018). First in human study to assess safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13520 (Original work published 2018)